文传商讯

Galderma’s Nemluvio (Nemolizumab) Granted Marketing Authorization in the United Kingdom and Switzer
2025-02-19 04:31:30

Galderma’s Nemluvio (Nemolizumab) Approved in the European Union for Moderate-to-Severe Atopic Derm
2025-02-17 22:44:14